Fit for Public Consumption. (Matters of Scale).

Fit for Public Consumption.

Amount of money U.S. drug companies                  $14 billion
spent on marketing in 1999

Amount of money the 12 largest drug                  $19 billion
companies spent on research and
development that year

Amount that BP (formerly British                    $100 million
Petroleum) is spending annually to
market its new name and its new
environmentally friendly image of
moving "beyond petroleum"

Amount that BP invests annually in clean            $100 million
energy (solar, wind, etc.) each year

U.S. military spending on the war in       at least $2.5 billion
Afghanistan

U.S. government spending on emergency             $0.320 billion
humanitarian aid to Afghanistan

U.S. funding for Plan Colombia, which               $1.3 billion
aims to halt illicit coca production
largely through military funding and
aerial spraying of herbicides

Share of this funding dedicated to                $0.081 billion
helping Colombian farmers shift to
legal crops

Wholesale price, per pill, Bayer                           $4.67
Corporation charges for the
anthrax-fighting antibioti Cipro

Approximate price that generic drugmakers                  $0.40
say they could profitably charge for
making the drug

SOURCES: Public Citizen report, "Analysis of Pharmaceutical Industry
Corporate Profits, 1999," 6 October 2000; "Dinner's On You," All Things
Considered, NPR, 23 July 2001; "BP Amoco Unveils New Global Brand to
Drive Growth," BP Press Release, 24 July 2000; Innovest Strategic Value
Advisors, Climate Change and Shareholder Value: Case Study of BP (New
York: 2001); "War experts: U.S. Campaign Cost-Effective," CNN.com, 14
December 2001; "Fighting Terror/Aiding a Nation; U.S. Cost to Rebuild
Afghanistan at Issue," The Boston Globe, 9 January 2002; "Stepped Up
Battle Against Coca Ignites Debate," The Miami Herald, 16 April 2001;
"Medicine as a Luxury," The American Prospect: Globalism and Poverty
supplement, winter 2002.